Antiviral drug resistance.
暂无分享,去创建一个
[1] A. Minson,et al. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. , 1989, The Journal of general virology.
[2] J. Oxford,et al. Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates. , 1986, The Journal of antimicrobial chemotherapy.
[3] D. Jeffries. The spectrum of cytomegalovirus infection and its management. , 1989, The Journal of antimicrobial chemotherapy.
[4] D. Richman,et al. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. , 1989, Science.
[5] C. Crumpacker,et al. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome. , 1989, The New England journal of medicine.
[6] R. Webster,et al. Emergence of amantadine-resistant H5N2 avian influenza virus during a simulated layer flock treatment program. , 1987, Avian diseases.
[7] H. Field,et al. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice , 1978, Journal of Hygiene.
[8] Brendan A. Larder,et al. Site-specific mutagenesis of AIDS virus reverse transcriptase , 1987, Nature.
[9] H. Otsuka,et al. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir , 1987, Antimicrobial Agents and Chemotherapy.
[10] D. Smee,et al. Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells. , 1985, Biochemical pharmacology.
[11] J. Skehel,et al. Molecular basis of resistance of influenza A viruses to amantadine. , 1986, The Journal of antimicrobial chemotherapy.
[12] B. Larder,et al. Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. , 1986, The Journal of general virology.
[13] B. Larder,et al. Characterization of abnormal thymidine kinases induced by drug-resistant strains of herpes simplex virus type 1. , 1983, The Journal of general virology.
[14] H. Field,et al. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir. , 1984, Antiviral research.
[15] D. Coen. General aspects of virus drug resistance with special reference to herpes simplex virus. , 1986, The Journal of antimicrobial chemotherapy.
[16] M. Rossmann. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids. , 1989, Antiviral research.
[17] O E Varnier,et al. Antiviral activity of coumermycin: identification of resistant and sensitive retrovirus strains. , 1985, Microbiologica.
[18] L. Corey,et al. Acyclovir prophylaxis for herpes simplex virus infection , 1987, Antimicrobial Agents and Chemotherapy.
[19] H. Field,et al. Analysis of the bovine herpesvirus type 1 thymidine kinase (TK) gene from wild-type virus and TK-deficient mutants. , 1989, The Journal of general virology.
[20] J. Skehel,et al. The molecular basis of the specific anti‐influenza action of amantadine. , 1985, The EMBO journal.
[21] B. Larder,et al. Virus drug-resistance: mechanisms and consequences. , 1984, Antiviral research.
[22] C. Schroeder,et al. Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic. , 1981, Acta virologica.